Skip Ribbon Commands
Skip to main content

UCHealth Home

:

Clinical Trials: GOG 0274: A Phase III Trial of Adjuvant Chemotherapy Following Chemoradiation as Primary Treatment for Locally Advanced Cervical Cancer Compared To Chemoraditiaon Alone: The Outback Trial ( ANZGOG 0902)

 


GOG 0274: A Phase III Trial of Adjuvant Chemotherapy Following Chemoradiation as Primary Treatment for Locally Advanced Cervical Cancer Compared To Chemoraditiaon Alone: The Outback Trial ( ANZGOG 0902)


Trial Focus

Female Reproductive Cancer

Objective

         This is a clinical trial of cisplatin that will be administered by IV plus Radiation Therapy which is standard of care and carboplatin and paclitaxel that will be administered by IV and is investigational.

IRB Protocol #

11-1502

Trial Status

OPEN

Principle Investigator

SAKETH GUNTUPALLI

Sponsor

GOG

Contact

REBECCA KISSANE at (720)848-7202 or REBECCA.KISSANE@UCDENVER.EDU

Location

University of Colorado Hospital University of Colorado Hospital

Eligibility and Other Participant Information


What To Expect : A screening period to determine eligibility. A treatment period(s) that can last up to 5 years. A follow up period will consist of clinic visits. // Eligibility criteria include but are not limited to 18 years or older with cervical cancer.Eligibility criteria include but are not limited to 18 years or older with cervical cancer.